ODDB.org: Open Drug Database

Fasturtec 1.5 mg / 1 ml, poudre et solvant pour solution à diluer pour perfusion - 3 Kombipackung(en) à 1.5 mg

Swissmedic Key	55789002	Registration Holder	Sanofi-Aventis (Suisse) SA
Name	Fasturtec 1.5 mg / 1 ml, poudre et solvant pour solution à diluer pour perfusion	Date of registration	05.04.2002
		Introduction of Sequence	05.04.2002
ATC-Classification	Rasburicase (V03AF07)	Revision date	28.04.2006
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	07.11.30.	Show package size	3 Kombipackung(en) à 1.5 mg
Index Therapeuticus (Swissmedic)	07.11.30.	Description	Flacons à 1.5 mg et ampoules de solvant à 1 ml
Swissmedic categorie.	A
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	PR
Deductible	k.A.	Consumer price	PR
Feedback	FB
GTIN	7680557890021	Medication Code	Biotechnologika
Pharmacode		Disponibility

Composition

Praeparatio sicca: rasburicasum 1.5 mg, alaninum, mannitolum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dodecahydricus, pro vitro corresp. natrium max. 2.1 mg. Solvens: poloxamerum 188, aqua ad iniectabile q.s. ad solutionem pro 1 ml.

Packungsbestandteile

Label

Solvens

Galenic Form

Injection preparation

Excipiens

Inactive agents	Dose
Poloxamer	188

Galenic Form

poudre et solvant pour solution à diluer pour perfusion

Excipiens

Active Agent	Dose	additional_information
Rasburicase	1.5 mg	Praeparatio sicca

Inactive agents
Alanine
Disodium Phosphate Dihydrate
Disodium Phosphate Dodecahydrate
Mannitol
Sodium Dihydrogenophosphate Dihydrate

Source

Data was imported : 04.05.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH